Managed Healthcare Executive Newsletter

To view this email as a web page, click here.

TOP STORIES

Drug costs are a hot political topic, but just how much do they disrupt healthcare?

How Immuno-Oncology Biomarkers Are Changing Cancer Care

With so many new immunotherapy treatments on the horizon, pharmacists need to understand the ins and outs of immuno-oncology biomarkers to best serve their patients.

Calls for “Structural Policy Changes” for Biosimilars Market

The Biosimilars Forum, in partnership with Medicines for Europe, says the U.S. can look to European policy directives to advance the biosimilars market.

DIGITAL EDITION

Check out our April issue featuring:

• The Changing Diabetes Landscape
• The Future of the ACA
• How to Engage Providers

3-minute case study: built-in documentation time

How can organizations reduce physicians’ after-hours documentation time to nearly zero? Read this 3-minute case study to see how OurHealth, an organization providing on-site healthcare at workplaces, has made physician overtime “almost nonexistent” with a simple schedule change. Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.